# FDA Inspection 1155967 - Rafarm S.A. - June 04, 2021

Source: https://www.keypedia.com/records/fda_inspections/rafarm-sa/78b90921-d386-4f46-9545-bd2ea23f48d8
Source feed: FDA_Inspections

> FDA Inspection 1155967 for Rafarm S.A. on June 04, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155967
- Company Name: Rafarm S.A.
- Inspection Date: 2021-06-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1300434 - 2024-06-21](https://www.keypedia.com/records/fda_inspections/rafarm-sa/a24b8d41-94b2-407f-a4d0-5ed1db63763e)
- [FDA Inspection 1225663 - 2023-05-19](https://www.keypedia.com/records/fda_inspections/rafarm-sa/b8f780cb-150f-479c-972b-49798ad3c1d3)
- [FDA Inspection 1123693 - 2020-03-11](https://www.keypedia.com/records/fda_inspections/rafarm-sa/0d18ea8e-dd55-4388-9680-c88b53caa1b0)
- [FDA Inspection 1111463 - 2018-05-31](https://www.keypedia.com/records/fda_inspections/rafarm-sa/6429f57b-1cfa-49d1-9f63-9c745663982a)

Company: https://www.keypedia.com/companies/rafarm-sa/147e9812-6247-4b31-82b4-c444b23955ce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c